针对急性白血病的CXCR4向治疗药物:破坏白血病细胞微环境相互作用与pentixafor和pentixather
Sana Rahimian1, Hossein Najafi2, Mohammad Doroudian3
1Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Islamic Republic of Iran.
Medical oncology (Northwood, London, England)
|August 3, 2025
概括
本综述探讨了针对急性白血病的CXCR4向治疗策略. 将成像与Pentixafor和放射治疗与Pentixather结合起来,可以提高治疗效率和患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- CXCR4/CXCL12信号通路对于白血病干细胞生存和骨髓利基中的治疗耐药性至关重要.
- 这个轴的失调有助于疾病的进展和急性白血病的预后不佳.
研究的目的:
- 审查使用Pentixafor和Pentixather治疗急性白血病的CXCR4导向的治疗术策略.
- 分析破坏白血病细胞利基相互作用的潜力,以提高治疗疗效.
主要方法:
- 使用Pentixafor用于对白血病细胞CXCR4表达的非侵入性成像.
- 采用Pentixather用于针对性向CXCR4阳性白血病细胞提供放射治疗.
- 分析CXCR4通路抑制对白血病细胞利基相互作用的影响.
主要成果:
- 潘蒂克萨福能够可视化CXCR4表达,有助于患者分层.
- 潘蒂克萨德提供有针对性的辐射,可能克服化学阻力.
- 破坏CXCR4介导相互作用可以提高急性淋巴细胞白血病 (ALL) 和急性髓性白血病 (AML) 的治疗疗效.
结论:
- 以CXCR4为导向的治疗方法为急性白血病治疗提供了一种新的策略.
- 整合成像和治疗推进了针对血液恶性瘤的个性化医学.
- 这一策略可能会保留功能性造血,改善整体患者护理和治疗结果.
关键词:
患有急性白血病的人.骨髓的利基是骨髓中的一个.CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4CXCR4C对于Pentixa,这是一个很好的选择.潘蒂克萨德的皮革热门节目 热门节目 热门节目更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.2K
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
7.7K
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K